SLDB logo

Solid Biosciences Inc. (SLDB) EBITDA

Annual EBITDA:

-$121.90M-$28.91M(-31.09%)
December 31, 2024

Summary

  • As of today, SLDB annual EBITDA is -$121.90 million, with the most recent change of -$28.91 million (-31.09%) on December 31, 2024.
  • During the last 3 years, SLDB annual EBITDA has fallen by -$52.61 million (-75.93%).
  • SLDB annual EBITDA is now -1757.13% below its all-time high of -$6.56 million, reached on December 31, 2015.

Performance

SLDB EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSLDBincome statement metrics

Quarterly EBITDA:

-$41.31M-$1.66M(-4.19%)
June 30, 2025

Summary

  • As of today, SLDB quarterly EBITDA is -$41.31 million, with the most recent change of -$1.66 million (-4.19%) on June 30, 2025.
  • Over the past year, SLDB quarterly EBITDA has dropped by -$14.75 million (-55.56%).
  • SLDB quarterly EBITDA is now -915.16% below its all-time high of -$4.07 million, reached on March 1, 2016.

Performance

SLDB Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSLDBincome statement metrics

TTM EBITDA:

-$155.14M-$14.75M(-10.51%)
June 30, 2025

Summary

  • As of today, SLDB TTM EBITDA is -$155.14 million, with the most recent change of -$14.75 million (-10.51%) on June 30, 2025.
  • Over the past year, SLDB TTM EBITDA has dropped by -$57.84 million (-59.46%).
  • SLDB TTM EBITDA is now -3712.66% below its all-time high of -$4.07 million, reached on March 1, 2016.

Performance

SLDB TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSLDBincome statement metrics

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

SLDB EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year-31.1%-55.6%-59.5%
3Y3 Years-75.9%-78.5%-87.0%
5Y5 Years-4.6%-134.2%-65.9%

SLDB EBITDA Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-75.9%at low-99.6%at low-79.6%at low
5Y5-Year-75.9%at low-155.7%at low-123.9%at low
All-TimeAll-Time-1757.1%at low-915.2%at low-3712.7%at low

SLDB EBITDA History

DateAnnualQuarterlyTTM
Jun 2025
-
-$41.31M(-4.2%)
-$155.14M(-10.5%)
Mar 2025
-
-$39.65M(-0.6%)
-$140.38M(-10.3%)
Dec 2024
-$121.90M(-31.1%)
-$39.41M(-13.3%)
-$127.27M(-16.2%)
Sep 2024
-
-$34.78M(-31.0%)
-$109.54M(-12.6%)
Jun 2024
-
-$26.55M(-0.1%)
-$97.29M(-0.4%)
Mar 2024
-
-$26.54M(-22.4%)
-$96.94M(+4.4%)
Dec 2023
-$92.99M(+4.0%)
-$21.68M(+3.8%)
-$101.36M(+6.2%)
Sep 2023
-
-$22.53M(+14.0%)
-$108.05M(-1.7%)
Jun 2023
-
-$26.20M(+15.3%)
-$106.22M(-3.0%)
Mar 2023
-
-$30.95M(-9.1%)
-$103.16M(-6.5%)
Dec 2022
-$96.87M(-39.8%)
-$28.37M(-37.1%)
-$96.87M(-12.1%)
Sep 2022
-
-$20.69M(+10.6%)
-$86.39M(-4.1%)
Jun 2022
-
-$23.14M(+6.2%)
-$82.97M(-6.6%)
Mar 2022
-
-$24.66M(-37.8%)
-$77.80M(-12.3%)
Dec 2021
-$69.29M(+16.1%)
-$17.89M(-3.5%)
-$69.29M(+3.7%)
Sep 2021
-
-$17.28M(+3.8%)
-$71.95M(+4.2%)
Jun 2021
-
-$17.97M(-11.2%)
-$75.13M(-0.4%)
Mar 2021
-
-$16.15M(+21.4%)
-$74.80M(+9.4%)
DateAnnualQuarterlyTTM
Dec 2020
-$82.54M(+29.1%)
-$20.55M(-0.4%)
-$82.54M(+11.7%)
Sep 2020
-
-$20.46M(-16.0%)
-$93.51M(+8.3%)
Jun 2020
-
-$17.64M(+26.2%)
-$102.01M(+7.8%)
Mar 2020
-
-$23.89M(+24.2%)
-$110.68M(+5.0%)
Dec 2019
-$116.49M(-57.2%)
-$31.52M(-8.9%)
-$116.49M(-9.0%)
Sep 2019
-
-$28.95M(-10.0%)
-$106.88M(-10.7%)
Jun 2019
-
-$26.31M(+11.4%)
-$96.53M(-9.6%)
Mar 2019
-
-$29.71M(-35.6%)
-$88.08M(-18.8%)
Dec 2018
-$74.12M(-36.2%)
-$21.91M(-17.7%)
-$74.12M(-10.4%)
Sep 2018
-
-$18.61M(-4.1%)
-$67.15M(-8.1%)
Jun 2018
-
-$17.86M(-13.5%)
-$62.13M(-10.8%)
Mar 2018
-
-$15.75M(-5.4%)
-$56.09M(-3.1%)
Dec 2017
-$54.41M(-113.2%)
-$14.94M(-10.0%)
-$54.41M(-13.0%)
Sep 2017
-
-$13.59M(-14.9%)
-$48.16M(-39.3%)
Jun 2017
-
-$11.82M(+15.9%)
-$34.57M(-52.0%)
Mar 2017
-
-$14.06M(-61.9%)
-$22.75M(-78.3%)
Dec 2016
-$25.52M(-288.8%)
-$8.69M(-113.5%)
-$12.76M(-213.5%)
Mar 2016
-
-$4.07M
-$4.07M
Dec 2015
-$6.56M
-
-

FAQ

  • What is Solid Biosciences Inc. annual EBITDA?
  • What is the all-time high annual EBITDA for Solid Biosciences Inc.?
  • What is Solid Biosciences Inc. annual EBITDA year-on-year change?
  • What is Solid Biosciences Inc. quarterly EBITDA?
  • What is the all-time high quarterly EBITDA for Solid Biosciences Inc.?
  • What is Solid Biosciences Inc. quarterly EBITDA year-on-year change?
  • What is Solid Biosciences Inc. TTM EBITDA?
  • What is the all-time high TTM EBITDA for Solid Biosciences Inc.?
  • What is Solid Biosciences Inc. TTM EBITDA year-on-year change?

What is Solid Biosciences Inc. annual EBITDA?

The current annual EBITDA of SLDB is -$121.90M

What is the all-time high annual EBITDA for Solid Biosciences Inc.?

Solid Biosciences Inc. all-time high annual EBITDA is -$6.56M

What is Solid Biosciences Inc. annual EBITDA year-on-year change?

Over the past year, SLDB annual EBITDA has changed by -$28.91M (-31.09%)

What is Solid Biosciences Inc. quarterly EBITDA?

The current quarterly EBITDA of SLDB is -$41.31M

What is the all-time high quarterly EBITDA for Solid Biosciences Inc.?

Solid Biosciences Inc. all-time high quarterly EBITDA is -$4.07M

What is Solid Biosciences Inc. quarterly EBITDA year-on-year change?

Over the past year, SLDB quarterly EBITDA has changed by -$14.75M (-55.56%)

What is Solid Biosciences Inc. TTM EBITDA?

The current TTM EBITDA of SLDB is -$155.14M

What is the all-time high TTM EBITDA for Solid Biosciences Inc.?

Solid Biosciences Inc. all-time high TTM EBITDA is -$4.07M

What is Solid Biosciences Inc. TTM EBITDA year-on-year change?

Over the past year, SLDB TTM EBITDA has changed by -$57.84M (-59.46%)
On this page